Skip to content

US · CDT · BIOTECHNOLOGY

CDT Equity Inc. (CDT) intrinsic value and stock valuation

$0.23as of 2026-11-21 · Mkt cap 1.74M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

CDT Equity Inc. DCF and intrinsic value

InvestorsCraft values CDT with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from CDT’s statements →

CDT Equity Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Biotechnology Naples, FL 34103 cdtequity.com

How the business is doing

Fiscal 2021–2025, USD

Revenue
$0.00
20212025
Net income
-$-39.22M
20212025
Free cash flow
-$-17.96M
20212025
Total equity
$1.26B
20212025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2021–2025, USD
20252024202320222021
Revenue$0.00$0.00$0.00$0.00$0.00
Operating income-$-36.76M-$-15.42M-$-5.26M-$-3.16M-$-3.17M
Net income-$-39.22M-$-17.8M-$-540K-$-4.89M-$-3.66M
EPSd-$-118.85M————
Operating cash flow-$-15.55M-$-9.68M-$-7.72M-$-2.27M-$-2.15M
Capital expenditure-$-2.4M-$-50K$0.00$0.00$0.00
Free cash flow-$-17.96M-$-9.73M-$-7.72M-$-2.27M-$-2.15M
Total assets$3.54B$4.19M$7.22M$10K$210K
Total debt$1.29B$7.46M$980K$2.01M$180K
Net debt$895.8M$6.9M-$-3.24M$2.01M$130K
Total equity$1.26B-$-6.79M-$-460K-$-10.09M$20K
Cash and short-term investments$389.9M$550K$4.23M$0.00$50K
Income statement
20252024202320222021
Revenue$0.00$0.00$0.00$0.00$0.00
Cost of revenue$0.00$0.00$0.00$0.00$0.00
Gross profit$0.00$0.00$0.00$0.00$0.00
Research and development expenses$5.05M$3.38M$90K$110K$280K
Selling, general and administrative expenses$31.7M$12M$5.17M$3.05M$2.89M
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$36.8M$15.4M$5.26M$3.16M$3.17M
Cost and expenses$36.8M$15.4M$5.26M$3.16M$3.17M
Interest income$30K$10K$10K$1.98M$0.00
Interest expense$320K$1.51M$210K$0.00$0.00
Depreciation and amortization$2.42M$460K$0.00$0.00$0.00
Ebitda-$-36.48M-$-15.84M$3.05M-$-4.89M-$-3.66M
Operating income-$-36.76M-$-15.42M-$-5.26M-$-3.16M-$-3.17M
Total other income/expenses, net-$-2.47M-$-2.38M$8.1M-$-1.73M-$-480K
Income before tax-$-39.22M-$-17.8M$2.84M-$-4.89M-$-3.66M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-39.22M-$-17.8M-$-540K-$-4.89M-$-3.66M
Weighted average shares outstanding$330K$0.00$0.00$0.00$0.00
Weighted average diluted shares outstanding$330K$0.00$0.00$0.00$0.00
Balance sheet
20252024202320222021
Cash and short-term investments$389.9M$550K$4.23M$0.00$50K
Net receivables$462.9M$490K$0.00$0.00$0.00
Inventory$402.4M$0.00$0.00$0.00$0.00
Total current assets$1.35B$2.71M$5.73M$0.00$100K
Property, plant and equipment, net$566M$300K$0.00$0.00$0.00
Goodwill and intangible assets$1.44B$1.44B$0.00$10K$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$2.19B$1.48M$1.49M$10K$110K
Total assets$3.54B$4.19M$7.22M$10K$210K
Accounts payable$361.4M$1.43M$210K$0.00$0.00
Short-term debt$0.00$7.35M$980K$170K$180K
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$697.5M$10.7M$1.8M$4.18M$190K
Long-term debt$1.29B$110K$0.00$1.83M$0.00
Deferred revenue, non-current$0.00$0.00$0.00$4.63M$0.00
Total non-current liabilities$1.58B$240K$5.88M$5.92M$0.00
Capital lease obligations$0.00$230K$0.00$0.00$0.00
Total liabilities$2.28B$11M$7.68M$10.1M$190K
Common stock$500K$10K$10K$10K$0.00
Retained earnings$1.41B-$-29.1M-$-11.3M-$-10.77M-$0.00
Accumulated other comprehensive income (loss)-$-97.2M$410K$410K$680K$0.00
Total equity$1.26B-$-6.79M-$-460K-$-10.09M$20K
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$1.29B$7.46M$980K$2.01M$180K
Net debt$895.8M$6.9M-$-3.24M$2.01M$130K
Cash flow statement
20252024202320222021
Net income-$-39.22M-$-17.8M-$-540K-$-4.89M-$-3.66M
Depreciation and amortization$2.42M$460K$0.00$0.00$0.00
Stock-based compensation$2.18M$1.63M$200K$0.00$0.00
Change in working capital$4.73M-$-140K-$-2.52M$600K$1.36M
Accounts receivable$0.00$0.00$0.00$0.00$0.00
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$430K$1.23M$210K$0.00$0.00
Net cash provided by operating activities-$-15.55M-$-9.68M-$-7.72M-$-2.27M-$-2.15M
Investments in property, plant and equipment-$-410K-$-50K$0.00$0.00$0.00
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-810K-$-40K$720K-$-180K$0.00
Common stock issued$19.7M$3.33M$150K$1.34M$1.21M
Common stock repurchased-$-110K$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$17.4M$6.07M$10.9M$2.45M$1.9M
Net change in cash$950K-$-3.67M$4.23M$0.00-$-250K
Cash at end of period$1.51M$550K$4.23M$0.00$0.00
Operating cash flow-$-15.55M-$-9.68M-$-7.72M-$-2.27M-$-2.15M
Capital expenditure-$-2.4M-$-50K$0.00$0.00$0.00
Free cash flow-$-17.96M-$-9.73M-$-7.72M-$-2.27M-$-2.15M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About CDT Equity Inc.

        Based in Naples, Florida, CDT Equity, Inc. commenced operations in October 2021. This firm, co-founded by David Joszef Tapolczay and Freda C. Lewis-Hall, focuses on aiding the advancement and market entry of clinical-stage medical innovations.

        CEO
        Andrew Regan
        Employees
        4
        Beta
        1.46

        Explore

        Frequently asked questions

        What is the intrinsic value of CDT Equity Inc. (CDT)?

        InvestorsCraft does not currently publish an intrinsic value for CDT. How the IC value is calculated.

        Is CDT undervalued?

        InvestorsCraft does not publish an undervaluation signal for CDT at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.